Faculty of 1000, today launches an innovative new product, F1000Trials (http://f1000.com/trials), designed to enable rapid discovery and understanding of articles about clinical trials.
Read MoreFaculty of 1000 (http://f1000.com) today announced a partnership with docwise (www.docwi.se) that will bring its F1000Prime article recommendations to the users of the docwise aggregated medical journal and news platform.
Read MoreF1000Research is delighted to announce the journal's membership of the Open Access Scholarly Publishers Association (OASPA) and the Committee on Publication Ethics (COPE), and its listing in the Directory of Open Access Journals (DOAJ) and the SHERPA
Read MoreF1000Research, an Open Access life-sciences journal launched in January 2013, has pioneered a uniquely fast and transparent Open Science Publishing model enabling research papers to be published within a week.
Read MoreTo celebrate the dedication of the F1000Prime Faculty in recommending papers of special importance across biology and medicine, Faculty of 1000 is delighted to announce the winners of the 2012 Faculty Member of the Year Awards.
Read MoreAn article published in F1000 Biology Reports discusses recent important advancements in the development of alternative methods of embryo evaluation and selection that could lead to improvements in the reliability of IVF treatments.
Read MoreFaculty of 1000, today announced the launch of a new application that helps researchers explore the scientific content in biology and medicine included in Elsevier's SciVerse platform.
Read MoreMaking Evidence-Based Medicine Actionable: Faculty of 1000 (F1000) and DynaMed™ Partner; Expanding the DynaMed Community to More than 4,000 Clinical Experts and Rapidly Identifying Practice-Changing Articles
Read MoreOn the 4th July 2001, Andrew Lumsden of the MRC Centre for Developmental Neurobiology, King's College London, and F1000 Section Head for Neurodevelopment, became the author of the first Faculty of 1000 (F1000) evaluation.
Read MoreA recently published paper from Vascular Biosciences (VBS) has been selected by the Faculty of 1000 (F1000) as one of the top 2 percent of all published articles in the biological and medical sciences in 2011.
Read More